Reacting to the revelation of a significant accounting error.
04/23/2012
https://www.congress.gov...
I am sure it is a concern of the two colleagues of mine.
The unsustainable growth in the costs of the Pell Grant program continues to be an anchor dragging down the entire budget for the Department...
But it holds promise for the people with cystic fibrosis and their families.
That would herald, if it were approved by FDA--It's in clinical trials now.